KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Goodwill & Intangibles (2017 - 2026)

Guardant Health's Goodwill & Intangibles history spans 9 years, with the latest figure at $103.2 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 926.65% to $103.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.2 million, a 926.65% increase, with the full-year FY2025 number at $103.2 million, up 926.65% from a year prior.
  • Goodwill & Intangibles hit $103.2 million in Q4 2025 for Guardant Health, up from $8.8 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for GH hit a ceiling of $103.2 million in Q4 2025 and a floor of $8.8 million in Q3 2025.
  • Historically, Goodwill & Intangibles has averaged $18.2 million across 5 years, with a median of $14.0 million in 2023.
  • Biggest five-year swings in Goodwill & Intangibles: decreased 19.2% in 2024 and later skyrocketed 926.65% in 2025.
  • Tracing GH's Goodwill & Intangibles over 5 years: stood at $17.5 million in 2021, then fell by 14.17% to $15.0 million in 2022, then decreased by 18.3% to $12.3 million in 2023, then fell by 18.09% to $10.0 million in 2024, then skyrocketed by 926.65% to $103.2 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for GH at $103.2 million in Q4 2025, $8.8 million in Q3 2025, and $9.2 million in Q2 2025.